Humalog ® (insulin lispro)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).

Is dose conversion needed when transitioning to the Humalog® (insulin lispro) 200 units/mL KwikPen® from the Humalog® (insulin lispro) 100 units/mL?

When transitioning from Humalog 100 units/ml to Humalog 200 units/ml, no dose conversion is needed.

UK_cFAQ_LIS215_CHANGING_NO_DOSE_ADJUSTMENT
UK_cFAQ_LIS215_CHANGING_NO_DOSE_ADJUSTMENT
en-GB

Dose Conversion

Do NOT perform dose conversion when using the Humalog (insulin lispro) 200 units/mL KwikPen (pen).1

The dose window shows the number of insulin units to be delivered and NO conversion is needed.1

Therefore, a patient receiving 20 units of Humalog 100 units/mL and transitioning to the Humalog 200 units/mL Pen should dial the Pen to 20 units to administer the same 20-unit dose of insulin lispro.2

References

1Humalog 200 units/ml KwikPen [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Date of Last Review: 15 June 2022


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request